OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy
Huijuan Song, Qi Su, Shi Wei-feng, et al.
Acta Biomaterialia (2022) Vol. 141, pp. 398-407
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3

Advancements and Applications of Injectable Hydrogel Composites in Biomedical Research and Therapy
Hossein Omidian, Sumana Dey Chowdhury
Gels (2023) Vol. 9, Iss. 7, pp. 533-533
Open Access | Times Cited: 38

Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1

Carbon Dots and Tumor Antigen Conjugates as Nanovaccines for Elevated Cancer Immunotherapy
Hongxin Liu, Zhigang Xie, Min Zheng
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 21

A state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system
Marjan Assefi, Mehrnaz Ataeinaeini, Ahmad Nazari, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104623-104623
Closed Access | Times Cited: 21

Human serum albumin as the carrier to fabricate STING-activating peptide nanovaccine for antitumor immunotherapy
Aixian Zheng, Zhaoyu Ning, Xiaorong Wang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100955-100955
Open Access | Times Cited: 7

Nanodrug Delivery Systems in Antitumor Immunotherapy
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7

Glutathione Depletion‐Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy
Huijuan Song, Hao Sun, Ningning He, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 9
Closed Access | Times Cited: 6

Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Nanotechnology-based multifunctional vaccines for cancer immunotherapy
Xiaoxue Xie, Ting Song, Yi Feng, et al.
Chemical Engineering Journal (2022) Vol. 437, pp. 135505-135505
Closed Access | Times Cited: 23

Toll-like receptor agonists as cancer vaccine adjuvants
Donghwan Jeon, Ethan C. Hill, Douglas G. McNeel
Human Vaccines & Immunotherapeutics (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 16

Gadolinium-based ultra-small nanoparticles augment radiotherapy-induced T-cell response to synergize with checkpoint blockade immunotherapy
Huijuan Song, Hao Sun, Ningning He, et al.
Nanoscale (2022) Vol. 14, Iss. 31, pp. 11429-11442
Closed Access | Times Cited: 20

The synthesis and preliminary immunological evaluation of a dual-adjuvant SARS-CoV-2 RBD vaccine: Covalent integration of TLR7/8 and iNKT cell agonists
Ying Xu, Jing Yang, Xiongyan Meng, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132258-132258
Closed Access | Times Cited: 4

Nano-Oncologic Vaccine for Boosting Cancer Immunotherapy: The Horizons in Cancer Treatment
Chao Chen, Yue‐Ping Xu, Hui Meng, et al.
Nanomaterials (2025) Vol. 15, Iss. 2, pp. 122-122
Open Access

Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses
Qiliang Yin, Ying Wang, Yipeng Xiang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 14

Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting
Harun Achmad, Yousif Saleh Ibrahim, Muataz Mohammed Al‐Taee, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109434-109434
Closed Access | Times Cited: 14

Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114243-114243
Open Access | Times Cited: 8

Peptide Assemblies for Cancer Therapy
Yuchen Qiao, Bing Xu
ChemMedChem (2023) Vol. 18, Iss. 17
Open Access | Times Cited: 8

A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant
Erin M. Euliano, Brett H. Pogostin, Anushka Agrawal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant
Erin M. Euliano, Brett H. Pogostin, Anushka Agrawal, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 2

Inosine pranobex-derived coordination complexes for self-adjuvant, self-carrier, and self-assembled vaccines in cancer immunotherapy
Xia Li, Shinya Hattori, Tomohiko Yamazaki, et al.
Applied Materials Today (2024) Vol. 39, pp. 102299-102299
Closed Access | Times Cited: 2

Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy
Xianhu Zeng, Yi Teng, Chunrong Zhu, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6031-6046
Open Access | Times Cited: 10

Supramolecular Coassembled Peptide Hydrogels for Efficient Anticancer Therapy by RNS‐Based PDT and Immune Microenvironment Regulation
Dan Wang, Hui Li, Dianyu Wang, et al.
Macromolecular Bioscience (2022) Vol. 22, Iss. 12
Closed Access | Times Cited: 9

Development of immune cell delivery system using biodegradable injectable polymers for cancer immunotherapy
Yuta Yoshizaki, Kenta Horii, Nobuo Murase, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123801-123801
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top